Hematopoietic and Lymphatic System Neoplasm study: Acupressure Therapy
Official title Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
ClinicalTrials.gov ID: NCT06723041
What this study is testing
- What it's testing
- This study aims to find out if acupressure is better than a fake version of the treatment for lowering anxiety caused by chemotherapy.
- Who it's for
- The study is looking for people with cancer who are currently receiving chemotherapy.
- What's involved
- Participants will receive acupressure, which involves applying gentle finger pressure to specific points on the body, or a placebo version of this treatment.
- Time commitment
- The source text does not specify the total duration of the study or the number of visits required.
You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- NURSE-LED INTERVENTION: Age \>= 18 years and be diagnosed with cancer
- NURSE-LED INTERVENTION: Undergoing systemic, antineoplastic therapy
- NURSE-LED INTERVENTION: Ability to provide oral consent
- NURSE-LED INTERVENTION: Willingness to undergo a nurse-led acupressure intervention
- NURSE-LED INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English
You likely can't join if
- Prior experiences with acupressure, or training in acupressure points
See the full eligibility criteria
- NURSE-LED INTERVENTION: Age \>= 18 years and be diagnosed with cancer
- NURSE-LED INTERVENTION: Undergoing systemic, antineoplastic therapy
- NURSE-LED INTERVENTION: Ability to provide oral consent
- NURSE-LED INTERVENTION: Willingness to undergo a nurse-led acupressure intervention
- NURSE-LED INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English
- NURSE-LED INTERVENTION: Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety)
- SELF-ADMINISTRATION INTERVENTION: Age \>= 18 years and be diagnosed with cancer
- SELF-ADMINISTRATION INTERVENTION: Undergoing systemic, antineoplastic therapy
- SELF-ADMINISTRATION INTERVENTION: Ability to provide oral consent
- SELF-ADMINISTRATION INTERVENTION: Willingness to undergo a nurse-led acupressure intervention
- SELF-ADMINISTRATION INTERVENTION: Willingness and ability to complete pre- and post-intervention questionnaires in English
- SELF-ADMINISTRATION INTERVENTION: Report acute anxiety as a 5 or higher on a scale for 0 (no anxiety) to 10 (severe anxiety)
- SELF-ADMINISTRATION INTERVENTION: Reports 2+/day anxiety episodes at home
- SELF-ADMINISTRATION INTERVENTION: Interested in learning self-administered acupressure
- Prior experiences with acupressure, or training in acupressure points
The study team makes the final eligibility decision.
Where it is enrolling
- Rochester, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Rochester, Minnesota, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.